X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infectious diseases (14) 14
humans (13) 13
index medicus (11) 11
female (9) 9
immunology (9) 9
male (9) 9
hiv (7) 7
middle aged (7) 7
hepatitis c virus (6) 6
hiv infections - complications (6) 6
ribavirin (6) 6
drug therapy (5) 5
genotype (5) 5
hepatitis c (5) 5
treatment outcome (5) 5
adult (4) 4
antiviral agents - administration & dosage (4) 4
hepatitis c, chronic - drug therapy (4) 4
hiv infections - drug therapy (4) 4
liver cirrhosis (4) 4
therapy (4) 4
virology (4) 4
acute coronary syndrome (3) 3
analysis (3) 3
antiretroviral drugs (3) 3
antiretroviral therapy (3) 3
antiviral agents (3) 3
antiviral drugs (3) 3
ccr5 antagonists (3) 3
cirrhosis (3) 3
cyclohexanes - therapeutic use (3) 3
darunavir (3) 3
direct-acting antivirals (3) 3
drug resistance (3) 3
emtricitabine (3) 3
hcv (3) 3
hepatocellular carcinoma (3) 3
hiv tropism (3) 3
hiv-1 - genetics (3) 3
hiv-1 - physiology (3) 3
human immunodeficiency virus--hiv (3) 3
infection (3) 3
interferon (3) 3
maraviroc (3) 3
phenotype (3) 3
prevention (3) 3
retrospective studies (3) 3
ribonucleic acid--rna (3) 3
sofosbuvir (3) 3
spain (3) 3
sustained virological response (3) 3
tenofovir (3) 3
thrombotic microangiopathy (3) 3
tools (3) 3
triazoles - therapeutic use (3) 3
virus diseases (3) 3
abacavir (2) 2
acute hepatitis (2) 2
administration, oral (2) 2
adults (2) 2
aged (2) 2
aids/hiv (2) 2
alteraciones neurológicas (2) 2
antiretroviral agents (2) 2
antiviral agents - therapeutic use (2) 2
carcinoma, hepatocellular - epidemiology (2) 2
ccr5 receptor antagonists (2) 2
chronic hepatitis (2) 2
chronic hepatitis-c (2) 2
clinical trials (2) 2
coinfection - drug therapy (2) 2
complications and side effects (2) 2
coreceptor usage (2) 2
diagnosis (2) 2
direct acting antivirals (2) 2
dolutegravir (2) 2
dosage and administration (2) 2
drug resistance, viral - genetics (2) 2
drug therapy, combination (2) 2
drug-related side effects and adverse reactions - epidemiology (2) 2
drug-related side effects and adverse reactions - pathology (2) 2
embarazo (2) 2
entry inhibitors (2) 2
genetic barrier (2) 2
health aspects (2) 2
hepacivirus - drug effects (2) 2
hepacivirus - genetics (2) 2
hepatitis (2) 2
hepatitis aguda (2) 2
hepatitis c - complications (2) 2
hepatitis c - drug therapy (2) 2
hepatitis c, chronic - complications (2) 2
hepatitis crónica (2) 2
hepatitis e (2) 2
hepatoma (2) 2
hiv fusion inhibitors - therapeutic use (2) 2
hiv infections - virology (2) 2
hiv patients (2) 2
hiv-1 - drug effects (2) 2
hiv-1 - isolation & purification (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Pérez, Ana Belén and Chueca, Natalia and García-Deltoro, Miguel and Martínez-Sapiña, Ana María and Lara-Pérez, María Magdalena and García-Bujalance, Silvia and Aldámiz-Echevarría, Teresa and Vera-Méndez, Francisco Jesús and Pineda, Juan Antonio and Casado, Marta and Pascasio, Juan Manuel and Salmerón, Javier and Alados-Arboledas, Juan Carlos and Poyato, Antonio and Téllez, Francisco and Rivero-Juárez, Antonio and Merino, Dolores and Vivancos-Gallego, María Jesús and Rosales-Zábal, José Miguel and García, Federico and Ocete, María Dolores and Simón, Miguel Ángel and Rincón, Pilar and Reus, Sergi and De la Iglesia, Alberto and García-Arata, Isabel and Jiménez, Miguel and Jiménez, Fernando and Hernández-Quero, José and Galera, Carlos and Balghata, Mohamed Omar and Primo, Joaquín and Masiá, Mar and Espinosa, Nuria and Delgado, Marcial and von-Wichmann, Miguel Ángel and Collado, Antonio and Santos, Jesús and Mínguez, Carlos and Díaz-Flores, Felícitas and Fernández, Elisa and Bernal, Enrique and De Juan, José and Antón, José Joaquín and Vélez, Mónica and Aguilera, Antonio and Navarro, Daniel and Arenas, Juan Ignacio and Fernández, Clotilde and Espinosa, María Dolores and Ríos, María José and Alonso, Roberto and Hidalgo, Carmen and Hernández, Rosario and Téllez, María Jesús and Rodríguez, Francisco Javier and Antequera, Pedro and Delgado, Cristina and Martín, Patricia and Crespo, Javier and Becerril, Berta and Pérez, Óscar and García-Herola, Antonio and Montero, José and Freyre, Carolina and Grau, Concepción and GEHEP-004 Study Group and GEHEP-004 Study Grp
Journal of Hepatology, ISSN 0168-8278, 11/2019, Volume 71, Issue 5, pp. 876 - 888
[Display omitted] •We provide recommendations on how to use resistance data and achieve 90% sustained virological response.•If no NS5A resistance-associated... 
Resistance testing | RASs | Treatment failure | HCV | Resistance-associated substitution | Ribavirin | Direct-acting antivirals | SOFOSBUVIR | PREVALENCE | REGIMENS | GENOTYPE 1 | THERAPY | HEPATITIS-C VIRUS | SUBSTITUTIONS | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ANTIVIRAL DRUGS | LIFE | Disease resistance | Antiviral agents | Hepatitis | Ritonavir | New combinations | Interferon | Hepatitis C
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
by Cahn, Pedro and Madero, Juan Sierra and Arribas, José Ramón and Antinori, Andrea and Ortiz, Roberto and Clarke, Amanda E and Hung, Chien-Ching and Rockstroh, Jürgen K and Girard, Pierre-Marie and Sievers, Jörg and Man, Choy and Currie, Alexander and Underwood, Mark and Tenorio, Allan R and Pappa, Keith and Wynne, Brian and Fettiplace, Anna and Gartland, Martin and Aboud, Michael and Smith, Kimberly and Cassetti, Lidia and David, Daniel and Figueras, Laura and Losso, Marcelo and Lopardo, Gustavo and Lupo, Sergio and Porteiro, Norma and Sánchez, Marisa and Bloch, Mark and Cooper, David and Finlayson, Robert and Kelleher, Anthony and Koh, Kenneth and Lewis, David and McMahon, James and Moore, Richard and Roth, Norman and Shields, Matthew and De Wit, Stephane and Florence, Eric and Goffard, Jean-Christophe and Demeester, Remy and Lacor, Patrick and Vandercam, Bernard and Vandekerckhove, Linos and Angel, Jonathan and Baril, Jean-Guy and Conway, Brian and De Pokomandy, Alexandra and Szabo, Jason and Walmsley, Sharon and Bouchaud, Olivier and Chidiac, Christian and Delobel, Pierre and Goujard, Cecile and Katlama, Christine and Molina, Jean-Michel and Pialoux, Gilles and Philibert, Patrick and Bogner, Johannes and Esser, Stefan and Krznaric, Ivanka and Lehmann, Clara and Spinner, Christoph and Stellbrink, Hans-Jurgen and Stephan, Christoph and Stoehr, Albrecht and Barchi, Enrico and Caramello, Pietro and Castelli, Francesco and Cattelan, Anna Maria and D'Arminio Monforte, Antonella and Di Biagio, Antonio and Di Perri, Giovanni and Gori, Andrea and Maggiolo, Franco and Menzaghi, Barbara and Migliorino, Guglielmo and Mussini, Cristina and Penco, Giovanni and Puoti, Massimo and Rizzardini, Giuliano and Gulminetti, Roberto and Lazzarin, Adriano and Quirino, Tiziano and Sighinolfi, Laura and Viale, Pierluigi and Amaya Tapia, Gerardo and Andrade Villanueva, Jaime and Granados Reyes, Enrique R and Perez Rios, Alma and Santoscoy Gomez, Mario and Den Hollander, Jan and Rijnders, Bart and Hidalgo, José A and Hercilla Vasquez, Luis and Illescas, Luis and Olczak, Anita and Mansinho, Kamal and Correia Pacheco, Patricia Paula and ... and GEMINI Study Team
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 143 - 155
Journal Article
AIDS, ISSN 0269-9370, 02/2019, Volume 33, Issue 2, pp. 269 - 278
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 14905 - 7
Hepatitis C virus (HCV) response to direct-acting antivirals (DAAs) may be influenced by the presence of resistance-associated substitutions (RASs). This study... 
VELPATASVIR | SUBSTITUTIONS | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | ELBASVIR | SIMEPREVIR PLUS SOFOSBUVIR | VIRUS GENOTYPE 1 | PHASE-3 | COMPENSATED CIRRHOSIS | ANTIVIRAL DRUGS | REGIMENS | Population | Interferon | Hospitals | Clinical medicine | Hepatitis C | Patients
Journal Article
AIDS, ISSN 0269-9370, 07/2018, Volume 32, Issue 11, pp. 1423 - 1430
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 11/2014, Volume 17, Issue 4 Suppl 3, pp. 19520 - n/a
Introduction In a previous interim 24‐week virological safety analysis of the PROTEST study [1], initiation of Maraviroc (MVC) plus 2 nucleoside... 
Journal Article
AIDS, ISSN 0269-9370, 01/2018, Volume 32, Issue 3, pp. 337 - 346
Journal Article
AIDS, ISSN 0269-9370, 11/2017, p. 1
BACKGROUND/AIMS:Data regarding the use of all-oral direct-acting antivirals (DAA) in HIV/HCV-coinfected patients with advanced liver fibrosis are required,... 
Journal Article
AIDS REVIEWS, ISSN 1139-6121, 04/2019, Volume 21, Issue 2, pp. 55 - 64
Journal Article
Infectio, ISSN 0123-9392, 12/2015, Volume 19, Issue 4, pp. 168 - 171
Notificamos un caso de microangiopatía trombótica, caracterizado por un proceso de agregación plaquetaria amenazante para la vida, que presentó afectación... 
INFECTIOUS DISEASES
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S866 - S866
Abstract Background Adherence to antiretroviral therapy (ART) to treat HIV remains a critical global health challenge given its relationship with individual... 
Journal Article
INFECTIO, ISSN 0123-9392, 10/2015, Volume 19, Issue 4, pp. 168 - 171
Notificamos un caso de microangiopatía trombótica, caracterizado por un proceso de agregación plaquetaria amenazante para la vida, que presentó afectación... 
Thrombotic microangiopathy | Síndrome coronario agudo | Microangiopatía trombótica | Human inmunodeficiency virus infection | Acute coronary syndrome | Infección por el virus de la inmunodeficiencia humana
Journal Article
Infectio, ISSN 0123-9392, 10/2015, Volume 19, Issue 4, pp. 168 - 171
We report on a case of thrombotic microangiopathy, defined as an extensive and dangerous intravascular platelet aggregation disorder, which progressed to... 
Thrombotic microangiopathy | Acute coronary syndrome | Human inmunodeficiency virus infection
Journal Article